Issue 7/2013
Content (12 Articles)
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
E. Conde, B. Angulo, E. Izquierdo, L. Paz-Ares, C. Belda-Iniesta, M. Hidalgo, F. López-Ríos
GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
A. González Martín, A. Redondo, M. Jurado, A. De Juan, I. Romero, I. Bover, J. M. Del Campo, A. Cervantes, Y. García, J. A. López-Guerrero, C. Mendiola, J. Palacios, M. J. Rubio, A. Poveda Velasco
Optimal management of breakthrough cancer pain (BCP)
Y. Escobar, A. Mañas, J. Juliá, R. Gálvez, F. Zaragozá, C. Margarit, R. López, A. Casas, A. Antón, J. J. Cruz
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis
T. Korkmaz, S. Seber, U. Kefeli, E. Sari, M. Canhoroz, B. Oven, E. Yildirim, N. Yasar, D. Aydin, O. Balvan, N. Sener, S. Yuksel, A. Mert, O. Polat, F. Yumuk, O. Kanat, M. Gumus, N. S. Turhal
Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma
J. Tang, H. Cai, L. Lin, P. Xie, W. Zhong, M. Tang
Management and outcome of ovarian malignancy complicating pregnancy: an analysis of 41 cases and review of the literature
T. Gui, D. Cao, K. Shen, J. Yang, C. Fu, J. Lang, X. Liu
Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer
Tarique N. Hasan, B. Leena Grace, Gowhar Shafi, Rabbani Syed
Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer
G. Huang, H. Hu, X. Xue, S. Shen, E. Gao, G. Guo, X. Shen, X. Zhang
Upregulation of microRNA-224 confers a poor prognosis in glioma patients
S. Lu, S. Wang, S. Geng, S. Ma, Z. Liang, B. Jiao
Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma
N. Imai, A. Kinoshita, H. Onoda, A. Iwaku, M. Oishi, K. Tanaka, N. Fushiya, K. Koike, H. Nishino, H. Tajiri
Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients
F. Pietrantonio, P. Biondani, M. Milione, F. Melotti, G. Bertarelli, F. Perrone, F. de Braud, L. Mariani, G. Fanetti, D. Cortinovis, M. Di Bartolomeo